versión On-line ISSN 1851-7617
Rev. argent. microbiol. v.41 n.4 Ciudad Autónoma de Buenos Aires oct./dic. 2009
Linden flower (Tilia spp.) as potential vehicle of Clostridium botulinum spores in the transmission of infant botulism
Área Microbiología, Departamento de Patología, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo, Centro Universitario, Parque General San Martín S/N, (5500) Mendoza, Argentina.
*Correspondence. E-mail: email@example.com
Infant botulism is an intestinal toxemia caused principally by Clostridium botulinum. Since the infection occurs in the intestinal tract, numerous food products have been investigated for the presence of C. botulinum and its neurotoxins. In many countries, people use linden flower (Tilia spp) tea as a household remedy and give it to infants as a sedative. Therefore, to help provide a clear picture of this disease transmission, we investigated the presence of botulinum spores in linden flowers. In this study, we analyzed 100 samples of unwrapped linden flowers and 100 samples of linden flowers in tea bags to determine the prevalence and spore-load of C. botulinum. Results were analyzed by the Fisher test. We detected a prevalence of 3% of botulinum spores in the unwrapped linden flowers analyzed and a spore load of 30 spores per 100 grams. None of the industrialized linden flowers analyzed were contaminated with botulinum spores. C. botulinum type A was identified in two samples and type B in one sample. Linden flowers must be considered a potential vehicle of C. botulinum, and the ingestion of linden flower tea can represent a risk factor for infant botulism.
Key words: Botulinum spores; Linden flower tea; Infant botulism.
El té de tilo como vehículo potencial de esporas de Clostridium botulinum en la transmisión del botulismo infantil. El botulismo del lactante es una toxiinfección causada, principalmente, por Clostridium botulinum. Debido a que esta infección ocurre en el tracto intestinal, la presencia de esta bacteria y sus neurotoxinas ha sido investigada en numerosos alimentos. En muchos países se utiliza el té de tilo (Tilia spp.) como sedante natural, el que se administra incluso a los lactantes. A fin de contribuir al esclarecimiento de la transmisión de esta enfermedad, se investigó la prevalencia y la carga de esporas botulínicas en esta hierba. Se analizaron 100 muestras de tilo comercializado a granel y 100 muestras de tilo industralizado en “saquitos”. Los resultados de prevalencia fueron analizados por el test de Fisher y la carga de esporas por la técnica del número más probable. Se halló una prevalencia de esporas de C. botulinum del 3% en el tilo comercializado a granel, con una carga de 30 esporas/100 g de hierba. En tanto, ninguna de las muestras en saquitos acusó la presencia del patógeno. Se identificaron tres cepas de C. botulinum, dos tipo A y una tipo B. En virtud de estos resultados, el tilo podría considerarse un potencial vehículo de esporas de C. botulinum y la administración de sus infusiones a menores y lactantes, un riesgo para la transmisión de la enfermedad.
Palabras clave: Esporas botulínicas; Té de tilo; Botulismo del lactante.
Infant botulism is an intestinal toxemia caused by botulinum neurotoxins (BoNT) mainly produced by Clostridium botulinum. Some unusual strains of C. butyricum and C. baratii that produce BoNT type E and F, respectively, were isolated from a few patients with infant botulism (2, 5, 7, 17, 23, 32). Most cases result from C. botulinum types A and B (2, 4); however, some rare bivalent strains, Ba and Bf, were identified in a few cases (6, 16, 18).
Swallowed botulinum spores germinate, multiply, and vegetative cells produce BoNT in situ (2, 32 ). Since these spores are ubiquitous and widely distributed in soil, environmental exposure has been identified as an important risk factor for infant botulism (13, 22, 27). Soil is the principal source of these spore-forming bacteria, and botulinum spores may be present in dust; therefore, they can contaminate agricultural products. Due to the fact that the infection occurs in the intestinal tract, numerous food products have been investigated for the presence of C. botulinum spores and BoNTs. Botulinum spores have been found in household dust (27), honey, corn syrup (25), and in some medicinal plants (8, 30). However, for most cases of infant botulism, the source of botulinum spores has not been identified (4, 13, 25, 32).
In many countries, teas prepared with medicinal plants are frequently given to infants as household remedy; therefore, ingestion of teas prepared with medicinal plants contaminated with botulinum spores could represent a risk for infant botulism. In Argentina, Tilia spp. (linden flower) tea is commonly given to infants and some physicians recommend this tea as a natural sedative. The US Food and Drug Administration (FDA) places linden flower on the generally-recognized-as-safe (GRAS) list based on the chemical composition of this herb. However, linden flowers could be contaminated with botulinum spores. These spores can resist high temperatures; therefore, boiling water to prepare linden flower tea does not destroy the spores, but, rather, activates them. For these reasons, our aim was to determine the prevalence and spore-load of botulinum spores in linden flowers. This information is important to help elucidate the transmission of infant botulism and prevent this illness.
MATERIALS AND METHODS
We examined 200 samples of linden flowers that were obtained from markets and herbal stores from Mendoza, Argentina. Two groups of 100 samples were analyzed: 1) unwrapped linden flowers, which are delivered in large amounts to the herbal store and sold by weight to the customer in individual paper or plastic bags from open containers; and 2) linden flowers in tea bags (industrialized linden flowers), which are industrially processed, packaged in tea bags, and sold in closed boxes.
The samples were transferred to sterile recipients and stored at room temperature until examination. Then, 4 g of each sample of linden flower was suspended in 40 ml of saline solution (0.15 M NaCl) in a sterile recipient with hermetic closing. Suspensions were vigorously shaken and filtered through sterile gauze; the filtrates were centrifuged at 12,000 × g for 10 min to concentrate the spores. The pellets were suspended in 4 ml of saline solution, and these suspensions were subjected to 10 min of heat shock at 80 °C. The suspensions were inoculated in a chopped-meat medium (CMM) (14) and incubated at 31 °C for 5 days. After incubation, broths were centrifuged at 12,000 x g for 20 min at 4 °C. Cultures without signs of proteolysis were treated by mixing equal volumes of the supernatant culture and 1% trypsin (1:250, Difco) and incubated at 31 °C for 1 h. We inoculated 0.5 ml of each supernatant (each sample), in duplicate, intraperitoneally in mice and observed the mice for 96 h for characteristic botulinal signs and/or death (28).
We cultivated each of the toxic cultures in each of the following three solid media by streaking the surface: 1) 1.5% agar, 2) 4% agar (9), and 3) egg yolk agar (11). The cultures were incubated at 31 °C in BBL jars with an atmosphere of 80% N2, 10% CO2, and 10% H2. After incubation for 24 h in the 1.5% agar media, 48 h in the 4% agar media, and 72 h in the egg yolk media, suspected colonies were transferred to CMM and incubated at 31 °C for 4 days. The presence of BoNT in each of these cultures (from isolated colonies) was investigated by inoculating broths in mice as previously described. To assure a pure culture, toxic broths were cultivated in solid media, and these cultures were incubated in aerobic and anaerobic conditions. We identified the genera Clostridium based on the following characteristics: gram positive, strict anaerobe, and spore-forming rods. The cell morphology of each pure culture was observed by using an optical microscope. Isolated strains were characterized by biochemical tests: acid production from sugars, reaction in milk, meat, and gelatine, nitrate reduction, indole, lecithinase, and lipase production; esculin hydrolysis, and volatile acids production in peptone-yeast extract-glucose medium by gas-liquid chromatography (10).
Serologic typing of the pure cultures was carried out by quantitative neutralization tests on toxic cultures with monovalent and polyvalent botulinum antitoxin (15). When the levels of BoNTs were not sufficient for a neutralization test, we cultivated strains by dialysis in a cellophane sack immersed in toxin-production medium (33). After incubation at 32 °C for 6 days, the contents of the cellophane sacks were centrifuged at 12,000 × g for 10 min at 4 °C and serially diluted twofold in buffered solution. Each dilution was inoculated intraperitoneally into six mice (0.5 ml per mouse). Deaths were recorded for 96 h, and the 50% lethal doses (LD50) were calculated by the Reed and Muench method (29).
The Fisher test was used to compare the prevalence of C. botulinum spores in the two groups of linden flowers (unwrapped linden flowers and linden flowers in tea bags).
For the three positive samples, the spore-load was estimated by the most probable number method (1). We use three dilutions (1:1, 1:5, and 1:25) and three tubes for each dilution. After 10 min of heat shock at 80 °C, 1 ml of each dilution was inoculated in each tube with CMM, and these cultures were incubated for 5 days at 31 °C. The presence of C. botulinum was detected by bioassay as described previously.
Prevalence of botulinum spores in linden flower. We detected C. botulinum spores in 3% (3/100) of unwrapped linden flower samples analyzed, but none of the industrialized linden flower samples appeared to be contaminated with these spores (0/100). The difference in the occurrence of botulinum spores between both types of samples was analyzed by the Fisher test, and results were not significant (ρ = 0.2462).
Spore-load of C. botulinum in linden flower. We detected 30 spores per 100 grams of linden flower in each of the three positive samples (95% confidence limits: 9-103 spores per 100 grams).
Phenotypic characteristics of strains of C. botulinum isolated from linden flower. We isolated three toxigenic strains of C. botulinum from positive samples of linden flower. The results of serological and biochemical test were the following:
1) Serological test. Botulinum neurotoxin type A was identified in two of the three positive samples and type B in only one sample.
2) Biochemical tests. All isolated strains were grampositive rods with oval and subterminal spores. The three strains isolated from linden flower produced acid from glucose. Mannitol, maltose, lactose, mannose, fructose, and sucrose were not fermented and nitrate was not reduced. Gelatine was liquefied. Indole and lecithinase were not produced. Esculin was hydrolyzed and lipase was produced. Milk and meat were digested. Acetic, propionic, butyric, isobutyric, valeric, isovaleric, and isocaproic acids were detected in peptone-yeast extractglucose medium cultures by gas-liquid chromatography. According to biochemical test results, the three strains corresponded to metabolic group I.
Prevalence of botulinum spores in linden flower. The prevalence of botulinum spores found in unwrapped linden flower (3%) was lower than that detected in the following medicinal plants: Matricaria spp. (chamomile) (9), Lippia turbinata (penny royal), Alternanthera pungens (khakiweed), Pimpinella anisum (anise), and Senna acutifolia (senna) (30) (Table 1). These medicinal plants can be contaminated with botulinum spores present in the environment (i.e. soil, dust). The soil is the principal source of botulinum spores and the height of the medicinal plants can be an important factor in the contamination with these spores. The linden tree is several feet high; therefore, linden flower is less easily contaminated with botulinum spores than other plants of minor height. On the contrary, chamomile, khakiweed, anise, penny royal, and senna are small shrubs growing close to the ground (Table 1); therefore, these plants are easily contaminated with botulinum spores. On the other hand, the high prevalence of C. botulinum found by Satorres et al. (1999) in penny royal, khakiweed, anise, and senna could not be real because of the few samples analyzed for each one of these species (Table 1).
Table 1. Prevalence of C. botulinum in medicinal plants
The prevalence of botulinum spores in linden flower was also lower than the 6-10% detected in honey (3, 13, 19, 20, 24, 31), but higher than that found in corn syrup (0.5%) (4). These spores have been detected in honey from various countries (3, 12, 19, 20, 24, 26, 34) and some studies have also considered honey consumption a risk factor for this illness. For these reasons, and because honey is not nutritionally essential, the United States public health agencies, all major pediatricians, and the honey industry have recommended not to feed infants younger than one year old with honey (4). Moreover, C. botulinum type B spores were found in approximately 0.5% (5 of 961) of light and dark corn syrup samples (20). However, in 1991 a FDA market survey of 738 corn syrup samples concluded that none contained C. botulinum spores (21). Therefore, although the possible role of corn syrup in infant botulism has been proposed, it is not a recognized source of botulinum spores or a risk factor for infant botulism (4).
Probably, the absence of these spores in industrialized linden flowers is due to the fact that the industrialization process reduces the contamination. Linden flowers in tea bags are usually dried in closed furnaces (25-30 °C), while unwrapped linden flowers are often dried in the open air or in sheds. Therefore, industrialized linden flowers are less exposed to contamination with spores present in environmental dust. In a previous study, we found similar results when comparing the prevalence of botulinum spores in unwrapped chamomile and chamomile in tea bags. Unwrapped chamomile showed a prevalence of 13% whereas chamomile in tea bags of only 2% (9). Because botulinum spores can be present in environmental dust, an important way to prevent contamination with C. botulinum of “unwrapped” herbs is to optimize the hygiene conditions in herbal stores and to keep these herbs in closed bags.
Spore-load of C. botulinum in linden flower. The minimum infective dose of C. botulinum spores for human infants is unknown; however, from estimates from exposure to spore-containing honey, this dose may be as low as 10 to 100 (3, 4). This value is higher than the spore-load detected in the three positive samples of linden flowers (30 spores per 100 grams); however, a cup of linden flower tea is prepared with several grams of this herb, and linden flower tea may be ingested by an infant several times a day, for many days. Therefore, repetitive doses of this tea could accumulate the minimun infective dose of C. botulinum necessary for infant botulism. This spore-load is similar to that detected in chamomile (30- 40 spores/100g) (9) and smaller than that detected in honey (5-80 spores/g) (3). However, infants may be more frequently given herbal teas than honey. In Mendoza, in western Argentina, epidemiological data of patients with infant botulism showed that 9.6% (10/104) had ingested herbal teas, while 4.8% (5/104) of patients were honeyfed (8). Moreover, a study about the use of alternative medicine in Mendoza showed that children are commonly given herbal teas (Femenía, Guida, Azcurra et al., personal communication ). An 18.92% of infants had ingested some kind of herbal teas, and linden flower tea was one of the most common teas given to infants. This 18.9% of infants (younger than one year old) had ingested teas prepared with the following medicinal plants: Matricaria spp. (64.3%), Tilia spp. (14.3%), Chenopodium ambrosioides (14.3%), Peumus boldus (7.1%), Eucalyptus spp. (7.1%), Pimpinella anisum (7.1%), Artemisia douglasiana (7.1%), and a mixture of Chamomilla recutita, A. pungens, Mentha viridis, L. turbinata, and Faeniculum vulgare (“té del niño”) (7.1%) (Femenía, Guida, Azcurra et al., personal communication).
Phenotypic characteristics of strains of C. botulinum isolated from linden flower. Serotypes A and B are the most frequently identified in cases of infant botulism around the world. In Argentina, between the years 1982 and 2006, C. botulinum type A has been identified in 99.75% (409/410) of patients with infant botulism whereas C. botulinum type B was detected in one case (9). Moreover, we observed that strains of C. botulinum isolated from linden flower and from infant botulism cases showed similar biochemical characteristics. These results suggest that C. botulinum strains present in linden flower could collaborate to produce infant botulism.
An important way to prevent the occurrence of infant botulism results from not giving infants food products in which the presence of botulinum spores has been reported. Results presented in this study suggest that unwrapped linden flowers are a potential vehicle of C. botulinum spores. Therefore, to minimize the risk of acquisition of infant botulism, we recommend that linden flower tea prepared with unwrapped linden flowers should not be given to infants under one year of age.
Acknowledgements. We thank María Isabel Farace (Chief of Sanitary Bacteriology Service) and Edgardo Castelli (Laboratory Staff) from the Administración Nacional de Laboratorios e Institutos de Salud (A.N.L.I.S.) “Dr. Carlos G. Malbrán” (Buenos Aires, Argentina), and Daniel Abdala Pacheco from Hospital Materno Infantil “Dr. Humberto J. Notti” (Mendoza, Argentina). This work was supported by grants from Facultad de Ciencias Médicas and Secretaría de Ciencia y Técnica, Universidad Nacional de Cuyo, Mendoza, Argentina. M.I. Bianco and C. Lúquez had fellowship assistance from CONICET, Argentina.
1. American Public Health Association. APHA Technical Committee on Microbiological Methods for Foods. In: Vanderzant C, Splittstoesser DF, editors. Compendium of Methods for the Microbiological Examination of Foods, 3rd ed., Washington D.C., 1992, p. 105-19. [ Links ]
2. Arnon SS. Creation and development of the public service orphan drug human botulism immune globulin. Pediatrics 2007; 119: 785-9. [ Links ]
3. Arnon SS, Midura TF, Damus K, Thompson B, Wood RM, Chin J. Honey and other environmental risk factors for infant botulism. J Pediatr 1979; 94: 331-6. [ Links ]
4. Arnon SS. Infant botulism. In: Feigen RD, Cherry JD, Saunders WB, editors. Textbook of Pediatric Infectious Disease, 4th ed., Philadelphia, 1998, p. 1758-66. [ Links ]
5. Aureli P, Fenicia L, Pasolini B, Gianfranceschi M, McCroskey LM, Hatheway CL. Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy. J Infect Dis 1986; 154: 207-11. [ Links ]
6. Barash JR, Arnon SS. Dual toxin-producing strain of Clostridium botulinum type Bf isolated from a California patient with infant botulism. J Clin Microbiol 2004; 42: 1713-5. [ Links ]
7. Barash JR, Tang TWH, Arnon SS. First case of infant botulism caused by Clostridium baratii type F in California. J Clin Microbiol 2005; 43: 4280-2. [ Links ]
8. Bianco MI. Botulismo del lactante: Transmisión por plantas medicinales y su inhibición por probióticos. Tesis de Doctorado. Facultad de Ciencias Exactas, Físico-Químicas y Naturales, Universidad Nacional de Río Cuarto. Córdoba, Argentina 2008. [ Links ]
9. Bianco MI, Lúquez C, de Jong, LIT, Fernández RA. Presence of Clostridium botulinum spores in Matricaria chamomilla (chamomile) and its relationship with infant botulism. Int J Food Microbiol 2007; 121: 357-60. [ Links ]
10. Centers for Disease Control. Laboratory Methods in Anaerobic Bacteriology. In: Dowell VR, Hawkins TM, editors. CDC Laboratory Manual, Atlanta, 1981. [ Links ]
11. Dezfulian M, McCroskey LM, Hatheway CL, Dowell VR. Selective medium for isolation of Clostridium botulinum from human feces. J Clin Microbiol 1981; 13: 526-31. [ Links ]
12. Fenicia L, Ferrini AM, Aureli P, Pocecco M. A case of infant botulism associated with honey feeding in Italy. Eur J Epidemiol 1993; 9: 671-3. [ Links ]
13. Fox CK, Keet CA, Strober JB. Recent advances in infant botulism. Pediatr Neurol 2005; 32: 149-54. [ Links ]
14. Giménez DF, Ciccarelli AS. Studies on strain 84 of Clostridium botulinum. Zentralbl Bakteriol [Orig] 1970; 215: 212-20. [ Links ]
15. Giménez DF, Giménez JA. Serological subtypes of botulinal neurotoxin. In: DasGupta BR, editor. Botulinum and Tetanus Neurotoxins, New York, 1993, p. 421-31. [ Links ]
16. Giménez DF. Clostridium botulinum subtype Ba. Zentralbl Bakteriol 1984; 257: 68-72. [ Links ]
17. Hall JD, McCroskey LM, Pincomb BJ, Hatheway CL. Isolation of an organism resembling Clostridium baratii which produces type F botulinal toxin from an infant with botulism. J Clin Microbiol 1985; 21: 654-5. [ Links ]
18. Hatheway CL, McCroskey LM. Examination of feces and serum for diagnosis of infant botulism in 336 patients. J Clin Microbiol 1987; 25: 2334-8. [ Links ]
19. Hauschild AHW, Hilsheimer R, Weiss KF, Burke RB. Clostridium botulinum in honey, syrups, and dry infant cereals. J Food Prot 1988; 51: 892-4. [ Links ]
20. Kautter DA, Lilly T, Solomon HM, Lynt RK. Clostridium botulinum spores in infant foods: a survey. J Food Prot 1982; 45: 1028-9. [ Links ]
21. Lilly T Jr, Rhodehamel EJ, Kautter DA, et al. Incidence of Clostridium botulinum spores in corn syrup and other syrups. J Food Prot 1991; 54: 585-7. [ Links ]
22. Lúquez C, Bianco MI, Sagua MD, Barzola CP, de Jong LIT, Degarbo SM, et al. Relationship between the incidence of infant botulism and the presence of botulinum toxinproducing Clostridia in the soil of Argentina, 1982-2005. J Pediatr Neurol 2007; 5: 279-86. [ Links ]
23. McCroskey LM, Hatheway CL, Fenicia L, Pasolini B, Aureli P. Characterization of an organism that produces type E botulinal toxin but which resembles Clostridium butyricum from the feces of an infant with type E botulism. J Clin Microbiol 1986; 23: 201-2. [ Links ]
24. Midura TF, Snowden S, Wood RM, Arnon SS. Isolation of Clostridium botulinum from honey. J Clin Microbiol 1979; 9: 282-3. [ Links ]
25. Midura TF. Update: infant botulism. Clin Microbiol Rev 1996; 9: 119-25. [ Links ]
26. Nakano H, Okabe T, Hashimoto H, Sakaguchi G. Incidence of Clostridium botulinum in honey of various origins. Jpn J Med Sci Biol 1990; 43: 183-95. [ Links ]
27. Nevas M, Lindström M, Virtanen A, Hielm S, Kuusi M, Arnon SS, et al. Infant botulism acquired from household dust presenting as sudden infant death syndrome. J Clin Microbiol 2005; 43: 511-3. [ Links ]
28. Notermans SH, Nagel J. Assays for botulinum and tetanus toxins. In: Simpson LL, editor. Botulinum and Tetanus Neurotoxins, Academic Press, San Diego. 1989, p. 319-31. [ Links ]
29. Reed LJ, Muench H. A simple method for estimating fifty per cent end points. Am J Hyg 1938; 27: 493-7. [ Links ]
30. Satorres SE, Alcaraz LE, Fernández RA, Centorbi ON. Isolation of Clostridium botulinum in medicinal plants. Anaerobe 1999; 5: 173-5. [ Links ]
31. Schocken-Iturrino RP, Carneiro MC, Kato E, Sorbara JOB, Rossi OD, Grebasi LER. Study of the presence of spores of Clostridium botulinum in honey in Brazil. FEMS Immunol Med Microbiol 1999; 24: 379-82. [ Links ]
32. Sobel J. Botulism. Clin Infect Dis 2005; 41: 1167-73. [ Links ]
33. Sterne M, Wentzel LM. A new method for the large-scale production of high-titre botulinum formol-toxoid types C and D. J Immunol 1950; 65: 175-83. [ Links ]
34. Sugiyama H, Mills DC, Kuo LJ. Number of Clostridium botulinum spores in honey. J Food Prot 1978; 41: 848-50. [ Links ]